Universite Montpellier I
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
4
Ending by 2030
Oct 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Programmable Volatile/Non-Volatile Memory Cell (US 9,042,157) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 2 fees due Dec 9 to 23, 2026 · next Dec 9
- 2 fees due Feb 18 to 25, 2027 · next Feb 18
- 1 fee due Mar 17, 2027The maintenance fee for Fluoroether Unit-Based Thermostable, Low-Tg and Thermosetting Cross-Linked Materials. (US 10,414,867) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Compact Volatile/Non-Volatile Memory Cell (US 9,224,463) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Nov 5, 2027The maintenance fee for Fusokines Involving Cytokines with Strongly Reduced Receptor Binding Affinities (US 10,640,542) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,536,318 | Chemical RNA Synthesis Method In force · High confidence | In force | High confidence | |
| US 8,425,879 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy In force · High confidence | In force | High confidence | |
| US 9,108,919 | Compounds Useful for Treating Cancer In force · Medium confidence | In force | Medium confidence | |
| US 8,722,318 | Method of Photochemical Hydrolysis-Polycondensation of Cross-Linkable Chromophores with Steric Hindrance, Catalysed by a Photogenerated Acid, and the Applications Thereof In force · High confidence | In force | High confidence | |
| US 9,061,999 | Compounds Useful for Treating Aids In force · High confidence | In force | High confidence | |
| US 9,042,157 | Programmable Volatile/Non-Volatile Memory Cell In force · High confidence | In force | High confidence | |
| US 9,224,463 | Compact Volatile/Non-Volatile Memory Cell In force · High confidence | In force | High confidence | |
| US 9,053,782 | Memory Cell with Volatile and Non-Volatile Storage In force · High confidence | In force | High confidence | |
| US 9,117,521 | Memory Cell with Volatile and Non-Volatile Storage In force · High confidence | In force | High confidence | |
| US 9,878,014 | Targeted Human-Interferon Fusion Proteins In force · High confidence | In force | High confidence |
Also on record, not counted in the 21: 11 patents in force now held by others · 10 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
11 abandoned